Lack of cell cycle regulation of telomerase activity in human cells.
暂无分享,去创建一个
J. Shay | D. Aisner | W. Wright | S. Holt | Jerry W. Shay | Shawn E. Holt
[1] J. Shay,et al. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] D. Shibata,et al. Telomerase activity in normal and neoplastic breast. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] H. W. Sharma,et al. Telomerase activity in normal human endothelial cells. , 1997, Anticancer research.
[4] S. Kyo,et al. Telomerase activity in human endometrium. , 1997, Cancer research.
[5] J. Shay,et al. Telomerase activity concentrates in the mitotically active segments of human hair follicles. , 1997, The Journal of investigative dermatology.
[6] J. Shay,et al. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit , 1996 .
[7] J. Shay,et al. Telomerase activity in human intestine. , 1996, International journal of oncology.
[8] K. Riabowol,et al. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. , 1996, Cancer research.
[9] M. Mandal,et al. Cell cycle-dependent modulation of telomerase activity in tumor cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Shay,et al. Regulation of telomerase activity in immortal cell lines , 1996, Molecular and cellular biology.
[11] E. Dmitrovsky,et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. , 1996, Cancer research.
[12] J. McDougall,et al. Telomerase activation by the E6 gene product of human papillomavirus type 16 , 1996, Nature.
[13] L. Gollahon,et al. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). , 1996, Oncogene.
[14] J. Shay,et al. Telomerase activity in human cancer. , 1996, Current opinion in oncology.
[15] J. Shay,et al. Telomerase activity in human germline and embryonic tissues and cells. , 1996, Developmental genetics.
[16] A. Sartorelli,et al. Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Shay,et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.
[18] M. Oshimura,et al. Restoration of the Cellular Senescence Program and Repression of Telomerase by Human Chromosome 3 , 1995, Japanese journal of cancer research : Gann.
[19] D. Broccoli,et al. Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Reddel,et al. Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.
[21] B. Leber,et al. Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.
[22] J. Shay,et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP) , 1995 .
[23] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[24] C. Greider,et al. Telomerase activity in germline and embryonic cells of Xenopus. , 1994, The EMBO journal.
[25] T. Kwok,et al. Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells. , 1994, Cancer research.
[26] J. Shay,et al. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. , 1993, Oncogene.
[27] C B Harley,et al. Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[28] C B Harley,et al. Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.
[29] J. Steitz,et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.
[30] J. Shay,et al. A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.
[31] C B Harley,et al. Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.
[32] C. Greider. Telomeres, telomerase and senescence , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.
[33] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[34] R. Myers,et al. Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.
[35] J. Shay,et al. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts , 1989, Molecular and cellular biology.
[36] A M Olovnikov,et al. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.
[37] J. Yudkin. Sugar and Disease , 1972, Nature.
[38] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.